… ) is one of the oxindole derivatives approved for the treatment of patients with … spectral
characteristics of Sunitinib. In the present work, IR and Raman spectra of Sunitinib is reported both …

… Accordingly, sunitinib is classified as a low-… this anti-cancer drug include fatigue, hypertension,
diarrhea, stomatitis, and hand–foot syndrome. Following the oral administration, sunitinib …

… used in the early studies to determine whether sunitinib treatment would result in a decrease
in tumor metabolism. Treatment with 50 mg daily of sunitinib for 4 weeks resulted in a more …

… Among 12 different compounds, sunitinib inhibited CDK5 with an IC 50 of 4.2 μM. In silico …
, sunitinib fitted 6 of 10 features of the CDK5 pharmacophore. In a cell‐based model, sunitinib …

… Blocking VEGF signaling with sunitinib, an anti-cancer drug and a receptor tyrosine … Sunitinib
facilitates the derivation of mESCs from blastocysts, and the mESCs maintained in sunitinib…

… robust drug delivery system with improved drug encapsulation efficiency, extended stability,
proper particle size and industrial upscaling for Sunitinib malate anti-cancer drug. … and drug …

… drug especially on nervous system as a result of direct injection. In this work, adsorption of
Sunitinib … These complexes can be appropriate nano-carrier for anti-cancer drug of Sunitinib. …

… The anti-cancer drug was however found to be thermally stable in methanol in the dark [3],
[8], [9]. Despite Z-SUT recognised photodegradation, a number of studies did not report on …

… So, based on these facts and similarities between endometriosis and cancer, the effect of
the anti-cancer drug sunitinib on peritoneal endometriosis was studied after producing it …

… This study shows the vascular complications of treatment with a TKI, sunitinib (SU11248), …
treatment with sunitinib in metastatic RCC [ 13 ]. Drug-related hypertension can occur with drug …